MSL
NVAX icon

Mackay Shields LLC’s Novavax NVAX Stock Holding History

Mackay Shields LLC’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,800
Closed -$3.41M – 1118
2021
Q1 		$3.41M Sell
18,800
-12,400
-40% -$2.47M 0.02% 569
2020
Q4 		$3.48M Sell
31,200
-1,800
-5% -$191K 0.02% 609
2020
Q3 		$3.58M Buy
33,000
+6,500
+25% +$792K 0.02% 537
2020
Q2 		$2.21M Buy
+26,500
New +$1.01M 0.02% 707

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Mackay Shields LLC's NVAX Position: Q2 2021 in Review

Mackay Shields LLC sold out of Novavax (NVAX) in Q2 2021, closing a stake of 18,800 shares — an estimated $3.41M sold.

Mackay Shields LLC first reported a position in NVAX in Q2 2020 and held it in 4 quarters. The position peaked at $3.58M in Q3 2020. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

  • Mackay Shields LLC reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 18,800 Novavax shares in Q2 2021, an estimated $3.41M.
  • Mackay Shields LLC first reported a position in Novavax in Q2 2020 and held it in 4 quarters.
  • Mackay Shields LLC's Novavax position peaked at $3.58M in Q3 2020.
  • 407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.